Carecloud Inc Stock Price, News & Analysis

CareCloud (NASDAQ: CCLD) announced leadership changes effective January 1, 2026 to accelerate its enterprise AI strategy and scale execution. A. Hadi Chaudhry will serve as Chief Strategy Officer to lead the company-wide AI platform and innovation; Stephen Snyder will serve as Chief Executive Officer to focus on disciplined execution, margin expansion, and scaling AI solutions across ambulatory and hospital markets.

The company highlighted recent margin expansion, improved cash flow consistency, and that it remains on track for its first year of positive EPS since going public. CareCloud also expanded into the inpatient software market via acquisitions of Medsphere Systems and the HFMA MAP App.

CareCloud (Nasdaq: CCLD) on Dec 15, 2025 launched stratusAI Desk Agent, an AI phone receptionist designed to automate patient phone access with 24/7, no-wait voice conversations and deep EHR/PM integration. The company says the solution handles front-desk workflows end-to-end, including appointment scheduling, triage, prescription refills, referrals, lab questions, and reminders. A customer quote reports the agent is managing nearly 80% of inbound calls at one practice. CareCloud positions stratusAI Desk Agent alongside stratusAI Voice Audit to deliver call monitoring, quality scoring, trending insights, and sentiment visibility. The product is available now to CareCloud customers and a live demo webinar is scheduled for Dec 17, 2025.

CareCloud (Nasdaq: CCLD / CCLDO) announced a formal plan to satisfy 14 months of unpaid dividends on its 8.75% Series B cumulative preferred stock by issuing double monthly payments starting with the January 2026 dividend (record date Jan 31, 2026; payment expected mid‑February 2026).

The arrears total approximately $3.9 million or $2.55 per share. Regular monthly dividends were fully reinstated in January 2025. The company says it will use internally generated cash flow (no common dilution) and expects arrears to be fully paid by the end of Q1 2027, while reserving the right to adjust timings for unforeseen circumstances.

CareCloud (Nasdaq: CCLD) reported third quarter 2025 results and raised full-year revenue guidance to $117–$119 million (previously $111–$114M). Q3 revenue was $31.1 million, up 9% year-over-year, marking six consecutive quarters of positive GAAP net income. Q3 GAAP net income was $3.1 million and adjusted EBITDA was $7.7 million (up 13% YoY). Nine-month revenue was $86.1 million (+4% YoY) and YTD adjusted EBITDA was $19.9 million. The company completed the Medsphere acquisition for a total purchase price of $16.5 million, reduced line-of-credit borrowings to $4.9 million, and launched an AI Center of Excellence to scale generative AI initiatives.

CareCloud (Nasdaq: CCLD) will present at the ThinkEquity Conference on October 30, 2025 at the Mandarin Oriental, New York City. The company's presentation is scheduled for 4:00 p.m. ET in the Lotus Suite East and will focus on AI innovation and its overall growth strategy.

CareCloud will also highlight four year-to-date transactions, including the Medsphere acquisition and the addition of HFMA’s MAP App, which the company says expanded its capabilities and client reach.

CareCloud (Nasdaq: CCLD) will present at the 2025 Maxim Growth Summit on October 22–23, 2025 at the Hard Rock Hotel New York City.

Presentation will highlight recent M&A activity (four transactions year‑to‑date, including the Medsphere acquisition in late August and the HFMA MAP App acquisition earlier this month), the Company’s AI roadmap and AI Center of Excellence scaling toward ~500 AI professionals, raised 2025 revenue guidance to $116–$118 million, positive free cash flow, resumption of preferred dividends, and inclusion in the Russell Microcap Index.

CareCloud (Nasdaq: CCLD) will release third quarter 2025 financial results for the period ended September 30, 2025 before the market opens on Thursday, November 6, 2025. A conference call for investors is scheduled for 8:30 a.m. Eastern Time the same day. A live webcast and presentation slides will be available at ir.carecloud.com/events; an audio-only option is available via dial-in numbers. A replay and slides will be posted roughly three hours after the call at the same link.

CareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B cumulative perpetual preferred shares for October, November and December 2025.

Key facts: monthly dividend per share $0.18229 for each series; Series A holders receive an additional payment tied to a prior 11% rate that equals $0.04688 (Oct), $0.01719 (Nov) and $0.00 (Dec); ex-dividend and record dates are the last day of each month (Oct 31, Nov 30, Dec 31, 2025); payment dates are Nov 17, 2025, Dec 15, 2025 and Jan 15, 2026.

Dividends are cumulative, calculated at 8.75% per annum on the $25 liquidation preference (equivalent to $2.1875 per annum per share). Previously converted Series A holders who converted on March 6, 2025 are not eligible for these payments.

CareCloud (NASDAQ: CCLD) has announced a definitive agreement to acquire HFMA's MAP App, a leading hospital benchmarking tool, with the deal set to close on October 1, 2025. The acquisition includes a long-term joint marketing agreement with the Healthcare Financial Management Association (HFMA).

MAP App, developed by HFMA and used by top hospitals nationwide, specializes in benchmarking and measuring revenue cycle management performance. CareCloud plans to enhance the tool's capabilities with AI-driven insights through its AI Center of Excellence, building on synergies from its recent Medsphere hospital IT business acquisition.

The partnership aims to expand MAP App's reach and capabilities while leveraging HFMA's network of 140,000 members. The acquisition is not expected to have a material financial impact on CareCloud in 2025.